ACM
ITCI
Altium Capital Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-75,000
| Closed | -$6.26M | – | 68 |
|
|
2024
Q4 | $6.26M | Sell |
75,000
-79,000
| -51% | -$6.6M | 1.78% | 16 |
|
|
2024
Q3 | $11.3M | Sell |
154,000
-39,000
| -20% | -$2.85M | 3.32% | 7 |
|
|
2024
Q2 | $13.2M | Buy |
193,000
+80,000
| +71% | +$5.48M | 5.39% | 4 |
|
|
2024
Q1 | $7.82M | Buy |
113,000
+42,000
| +59% | +$2.91M | 3.09% | 9 |
|
|
2023
Q4 | $5.09M | Buy |
71,000
+43,000
| +154% | +$3.08M | 3.45% | 12 |
|
|
2023
Q3 | $1.46M | Buy |
+28,000
| New | +$1.46M | 0.76% | 28 |
|
|
2023
Q1 | – | Sell |
-100,000
| Closed | -$5.29M | – | 114 |
|
|
2022
Q4 | $5.29M | Hold |
100,000
| – | – | 2.69% | 9 |
|
|
2022
Q3 | $4.65M | Buy |
100,000
+25,000
| +33% | +$1.16M | 1.71% | 11 |
|
|
2022
Q2 | $4.28M | Buy |
75,000
+52,500
| +233% | +$3M | 1.71% | 14 |
|
|
2022
Q1 | $1.38M | Buy |
+22,500
| New | +$1.38M | 0.46% | 68 |
|
|
2021
Q2 | – | Sell |
-88,326
| Closed | -$3M | – | 160 |
|
|
2021
Q1 | $3M | Sell |
88,326
-65,022
| -42% | -$2.21M | 0.83% | 50 |
|
|
2020
Q4 | $4.88M | Buy |
+153,348
| New | +$4.88M | 1.82% | 13 |
|